US20060004269A9 - Impedance spectroscopy based systems and methods - Google Patents

Impedance spectroscopy based systems and methods Download PDF

Info

Publication number
US20060004269A9
US20060004269A9 US10656997 US65699703A US2006004269A9 US 20060004269 A9 US20060004269 A9 US 20060004269A9 US 10656997 US10656997 US 10656997 US 65699703 A US65699703 A US 65699703A US 2006004269 A9 US2006004269 A9 US 2006004269A9
Authority
US
Grant status
Application
Patent type
Prior art keywords
electrode
specimen
method
concentration
system
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
US10656997
Other versions
US7315767B2 (en )
US20040147819A1 (en )
Inventor
Andreas Caduff
Etienne Hirt
Thomas Schrepfer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PENDRAGON MEDICAL Ltd
Original Assignee
PENDRAGON MEDICAL Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N22/00Investigating or analysing materials by the use of microwaves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/05Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radiowaves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/11Automated chemical analysis
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/14Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333Saccharide [e.g., DNA, etc.]
    • Y10T436/144444Glucose

Abstract

One aspect of the invention provides a device that non-invasively determines the concentration of a substance in a target. The device includes a first electrode, a measuring circuit, and a data processor. In one embodiment of the device, the first electrode can be electrically insulated from the target, e.g., a cover layer of insulating material covers the first electrode.

Description

    CROSS-REFERENCE TO RELATED APPLICATIONS
  • This application claims priority to, and benefit of, U.S. provisional patent application Ser. No. 60/408,377, filed Sep. 5, 2002, entitled “METHODS AND DEVICES FOR DETERMINING THE CONCENTRATION OF A SUBSTANCE IN A TARGET” and incorporated herein by reference in its entirety. This application also claims priority to, and benefit of, U.S. patent application Ser. No. 09/980,661, filed Nov. 15, 2001 and entitled “Method and Device for Determining the Concentration of a Substance in Body Liquid” which claims priority to PCT application No. PCT/IB01/00334 filed Mar. 6, 2001 and entitled “Method and Device for Determining the Concentration of a Substance in Body Liquid.”
  • TECHNICAL FIELD
  • The invention relates to systems, methods and devices for non-invasively determining the concentration of a substance in a target. Examples of targets include an in-vitro or an in-vivo target containing body liquid, a non-body liquid target such as wastewater or beer, and a non-liquid target such as baby food or biological tissue. One can apply the invention in fields such as biotechnology, medicine, industry, environmental monitoring, agriculture, and manufacturing (such as food manufacturing).
  • BACKGROUND OF THE INVENTION
  • One application of conventional impedance spectroscopy is to attempt to determine the concentration of glucose and other substances in body fluids. In particular, this technology is of substantial interest for the determination of glucose concentration in blood and/or inter- or intracellular liquid.
  • It is well known that glucose and electrolyte concentrations vary in blood and underlying tissues. Several techniques for providing glucose analysis are known. These techniques permit subjects to determine their own glucose levels. Unfortunately many such techniques require invasive sampling of the subject.
  • Impedance spectroscopy practitioners have attempted to determine glucose concentration noninvasively. Stated another way, impedance spectroscopy practitioners have attempted to determine glucose concentration in a body liquid by analyzing the interaction of electromagnetic waves with the target material. The goal of such a technique is to provide a non-invasive in-vivo analysis.
  • U.S. Pat. No. 5,792,668, incorporated herein by reference in its entirety, describes one example of a device for measuring blood level glucose. According to this patent, one brings two electrodes into direct contact with the human body and attempts to measure the impedance between the electrodes.
  • However, one drawback of conventional impedance spectroscopy involving the direct contact of two electrodes with the human body is that the results often depend to some extent on variables affecting the electrical contact between the body and the electrodes, such as variables describing the surface condition of the body at the point of contact. As a consequence, such techniques have limited resolution in the measurement of the concentration of blood level glucose. Thus, a need remains for methods and systems for the accurate, effective, and noninvasive determination of the concentration of a substance (such as glucose) in a target (such as a body liquid). Furthermore, a need remains for methods and systems for non-invasively determining the concentration of a substance in a target, the methods and systems being applicable in other contexts such as in environmental monitoring and in food processing.
  • SUMMARY OF THE INVENTION
  • The invention relates to systems, methods and devices for accurately and effectively determining the concentration of a substance in a target. Examples of targets include: an in-vitro or an in-vivo target containing body liquid; non-body liquids such as wastewater or beer; and non-liquids such as baby food or biological tissue. One can apply the invention in fields such as biotechnology, medicine, industry (such as corrosion testing), environmental monitoring, agriculture, and manufacturing (such as food manufacturing).
  • In a first aspect of the invention, the invention provides a device that determines the concentration of a substance in a target. The device includes a first electrode, a signal source, a measuring circuit, and a data processor.
  • In one embodiment of the device, the first electrode can be electrically insulated from the target, e.g., a cover layer of insulating material covers the first electrode. Hence, the measured parameter(s), e.g., the magnitude of the impedance, does not depend on the surface conditions of the target to the extent it does when two electrodes are in direct contact with a target. Rather, the device capacitively couples a signal to the target and the measured parameter depends therefore primarily on the conditions within the target. The parameter measured in this way can then be converted to the desired concentration, e.g., by using calibration data.
  • Depending on the frequency, in one embodiment the first electrode is part of a sensor, e.g., a microstrip nearfield antenna or at lower frequencies a fringing capacitor. In one embodiment the microstrip nearfield antenna includes a microstrip electrode, i.e., the first electrode, surrounded by a ground electrode. In this two-electrode embodiment, a modulated voltage is applied between the microstrip electrode and the ground electrode. By using two electrodes, a defined field can be established within the target. One embodiment of a method according to the present invention places the second electrode, i.e., the ground electrode, in electric contact with the target.
  • The measured parameter preferably depends on the electrical impedance of the sensor. It has been found that the concentration of various substances in the target, for example substances that can change electrical properties of the target (such as colloids suspensions, electrolytes, bio molecular solutions, dyes etc., affects the impedance because it changes the loss (i.e., loss of power) properties and/or the dielectric properties of the target.
  • In one embodiment, the sensor forms part of a resonant circuit, which is operated at or close to its resonance frequency. Under such conditions, a change of the dielectric properties or loss properties of the target leads to shifts in the parameters of the resonant circuit and can therefore be measured.
  • The target can be a liquid including body liquids such as blood, extracellular fluid, intracellular fluid, interstitial fluid, and transcellular fluid, measured in vivo or in vitro. The device also can be used to measure tissue flux in a body. Various diseases can impede tissue flux, i.e., microvascular blood flow, reducing supply of necessary molecules leading to alterations in the skin and tissue structure and thus having an im pact on the impedance pattern produced by the tissue in question.
  • Embodiments of the invention also can be used with targets containing non-body liquids such as water in rivers, lakes, puddles, streets, waste-treatment systems, liquids present in foodstuffs, liquids present in growing crops, and liquids used during manufacturing processes.
  • Embodiments of the invention provides systems for measuring the concentration of a substance in a target, such as the glucose level in blood or tissue. The systems include a sensor having a strip electrode and a ring electrode arranged at the target. In one embodiment, the ring electrode is adapted for direct electrical contact with the target while the strip electrode is electrically insulated therefrom (in an alternative embodiment, the strip electrode can be in electrical contact with the target and the ring electrode be electrically isolated from the target). The strip electrode is adapted to provide a large interaction length with the target. The ring and strip electrodes form a capacitor in a resonant circuit. A modulated voltage in the MHz range close to or at the resonance frequency is applied to the electrodes and the system measures the response of the target. This arrangement permits a high accuracy measurement.
  • In another aspect, the invention provides a method for determining the concentration of a substance in a target. The method includes arranging a sensor, e.g., a microstrip nearfield antenna (having a microstrip electrode) at the target wherein at least part of the sensor can be electrically insulated from the target. The method includes applying a modulated electrical voltage to the sensor for generating a modulated field in the target. The method further includes measuring at least one parameter (for example the amplitude or the impedance, the phase shift, and/or the frequency), the parameter depending on a response of the target to the field. The method also includes determining the concentration of the substance in the target based at least in part on the measured parameter
  • In one embodiment, the method can include providing a sensor (e.g., a microstrip nearfield antenna with both a microstrip electrode and a second, ground electrode and placing the second, ground electrode in electrical contact with the target), so that, in the antenna example, the modulated electrical voltage is applied between the microstrip and the ground electrodes.
  • In another embodiment, the method includes measuring the temperature of the target and using the measured temperature in the determination of the concentration. In at least one embodiment, the response of the target is measured by arranging a near field microstrip antenna in proximity to the target.
  • One can use embodiments of the invention for in-vivo measurements of the human body. Thus, embodiments of a device according to the invention include an elongate electrode having a width much smaller than its length. Embodiments of the invention also include a holder to mount the elongate electrode to an arm or a leg with the longitudinal axis of the electrode extending parallel to the longitudinal axis of the arm or leg.. The methods and devices of this aspect of the invention have been found to be especially suited for measuring the glucose concentration in body fluid.
  • One can also use embodiments of the device according to the invention in other medical and/or biochemical applications. Such applications include: monitoring the concentrations of substances such as glucose or sodium chloride during biochemical processes; detection of changes in tissues of the body, such as those resulting from inflammatory processes in skin and underlying tissues, skin or breast cancer, and edemas; measuring tissue flux; and tracking concentrations of substances in infusions, fermenters, and cell suspensions.
  • In addition, one can use embodiments of the invention in industrial applications. Industrial applications include: waste water analysis; measuring salt in bodies of water including street water; corrosion testing, and environmental monitoring.
  • Still other applications of embodiments of a device according to the invention include monitoring the growth and harvesting of agricultural products and food and beverage processing applications. For example, one can use embodiments of the invention in connection with production of brewed and/or fermented beverages, production of baby food, production of dairy products, growing of agricultural products, and production of ingredients used in food and beverage processing, such as high fructose corn syrup.
  • Still another embodiment of the invention provides a system for measuring the concentration of a substance, e.g., a polluting or toxic substance, in a target, such as in product flow or in wastewater. In one embodiment, the system includes a sensor (e.g., a microstrip nearfield antenna, having a microstrip electrode surrounded by a ground electrode) arranged at the target. In the antenna example, the ground electrode is adapted for direct electrical contact with the target while the microstrip electrode can be electrically insulated there from. The ground and microstrip electrodes form a capacitor in a resonant circuit. The system is adapted to apply a modulated voltage in the appropriate range for the target, e.g., in the MHz range, and close to or at the resonance frequency of the circuit. The system is adapted to apply the appropriate range to the electrodes and the system measures the response of the target.
  • The system can include or can be adapted to interface with a process control device such that the process being observed is managed at least under certain circumstances (e.g., when a specified concentration of a pollutant is exceeded during the process) based on impedance spectroscopy data.
  • Details relating to these and other embodiments and aspects of the invention are described more fully in the detailed description and with reference to the accompanying drawings.
  • BRIEF DESCRIPTION OF THE DRAWING
  • The invention will be better understood and objects other than those set forth above will become apparent when consideration is given to the following detailed description thereof. Such description makes reference to the annexed drawings, wherein:
  • FIG. 1 is a block circuit diagram of a one embodiment for carrying out the invention,
  • FIG. 2 is a view onto a possible embodiment of the device,
  • FIG. 3 is a section along line III-III of FIG. 2,
  • FIG. 4 is the device of FIG. 3 with a wristband,
  • FIG. 5 shows the behavior of the relative amplitude A as a function of frequency,
  • FIG. 6 is a second embodiment of the circuit,
  • FIG. 7 is an alternative electrode geometry,
  • FIG. 8 a third embodiment of the circuit,
  • FIG. 9 is a schematic of a system using the circuit of FIG. 1, in accordance with an embodiment of the invention,
  • FIGS. 10A-F illustrate alternative embodiments of systems or portions of systems for monitoring processes such as the process illustrated in FIG. 9, and
  • FIG. 11 is a block circuit diagram of an alternative embodiment to the embodiment of FIG. 1 for carrying out the invention.
  • The drawings are not necessarily to scale, emphasis instead generally being placed upon illustrating the principles of the invention.
  • DETAILED DESCRIPTION OF THE INVENTION
  • FIG. 1 shows a block circuit diagram of one embodiment of a device according to the invention. The device includes a voltage controlled oscillator (VCO) 1 as a signal source for generating a waveform, e.g., a sine wave signal, the frequency of which depends on an input control voltage. This signal is fed to two amplifiers 2, 3 (In the alternative embodiment of FIG. 11, the signal is fed to a single amplifier 2). The output of first amplifier 2 is connected via a resistor R1 to a first signal path 4. A resonant circuit 5 comprising an inductance L and a capacitor C in series is connected between first signal path 4 and ground. The output of second amplifier 3 is connected via a resistor R2 to a second signal path 6. Second signal path 6 is substantially identical to first signal path 4 but comprises a resistor R3 as a reference load instead of resonant circuit 5.
  • Both signal paths 4, 6 are fed to a measuring circuit 7, which determines the relative amplitude A of both signals as well as, optionally, their mutual phase shift, phi. Relative amplitude A can be, e.g. the amplitude of first signal path 4 in units of the amplitude of second signal path 6 (wherein the amplitudes are the peak values of the sine waves). In one embodiment, circuit 7 is a conventional circuit for measuring the relative amplitude of both signals.
  • The output signal of measuring circuit 7 is fed to a microprocessor 8, which also controls the operation of VCO 1.
  • As can be seen from FIG. 1, the device in the present embodiment further includes a temperature sensor 10, a display 11 and an input device 12 with user operable controls, all of which are coupled to microprocessor 8.
  • Inductance L of the device of FIG. 1 can be generated by a coil and/or by the leads and electrodes of capacitor C. The inductance values can range depending on various factors including the substance and target of interest. In the case of determining the concentration of glucose in a body liquid, the inductance value ranges between about 220 nH and about 470 nH. One embodiment uses a value of about 330 nH.
  • A sensor (e.g., a near field microstrip an tenna, making up part of the capacitor C of the device of FIG. 1) probes a target. In other words, the device of FIG. 1 includes a capacitor C having electrodes adapted for placement near the target. In one embodiment, the near field microstrip antenna is located close to the target but remote from the rest of the device of FIG. 1. This arrangement can be useful in situations where the target itself may present an environment that could be damaging to all or part of the device (e.g., applications where the target comprises running water, such as waste water monitoring and/or environmental monitoring). With reference to FIGS. 6 and 7, in one embodiment, the device of FIG. 1 includes an extra antenna electrode 33 that is in electrical communication with the device but is located remote from the device.
  • The geometry of the electrodes is such that the electric field generated by them extends into the target. Representative examples of suitable geometries are discussed below. As mentioned above, at least one of the electrodes of the capacitor is electrically insulated from the target such that capacitor C is primarily a capacitive load, the capacitance and loss of which depends on the electrical properties (i.e. the response) of the target at the frequency of VCO 1.
  • The depth of the electromagnetic fields produced is strongly dependent on the electrode/antenna geometry (defined by the distance of the microstrip and the ground electrodes as well as by the shape of the microstrip antenna/electrode itself). Decreasing the distance between the microstrip electrode and the ground electrode increases the density of the electromagnetic field lines produced by the electrodes. The shape of the microstrip antenna itself has an impact as well. More generally, the configuration (e.g., frequency used) and dimensions of a sensor for use with the invention depend on the application (e.g., water content and dimensions of the object).
  • To measure the concentration of a substance in the fluid of the target, one embodiment of microprocessor 8 can initiate a measurement cycle consisting of a frequency sweep of VCO 1. The sweep can start at a frequency fmin below the expected resonance frequency f0 of the resonant circuit 5 and extend to a frequency fmax above resonance frequency f0. The sweep from fmin to fmax can occur as a single sweep or as a sequence of discrete sweeps. Each sweep provides a set of data points useful in calculating the concentration of the substance in the liquid. In one embodiment, the VCO is a symmetrical VCO to provide low harmonics and is a FET implementation providing a relatively wide frequency range. A symmetrical VCO cancels out most of the first harmonic because a differential signal is used. A FET implementation provides a higher frequency range as less parasitic capacitance exists in the resonating circuit because the FET Gate can be controlled directly avoiding a capacitive coupled feedback.
  • Note also that the range of the frequency sweep may be influenced by the application and/or the equipment used. For example, sweeps performed on a living body may use a lower fmax than sweeps performed on a target other than a living body. During the sweep or series of sweeps, the electrical properties of signal path 4 will change substantially, while those of signal path 6 will vary only slightly. The amplitude determined by measuring circuit A will therefore fall to a minimum A0 at f0, as shown in FIG. 5. At the same time, phase shift phi crosses zero.
  • FIRST EXAMPLE APPLICATION Measurement, e.g., In Vivo Measurement, of a Substance, e.g., Glucose, in a Body Liquid, e.g., Blood
  • The specific conductivity ρ(f) and the dielectric constant ∈(f) for a given fluid vary depending on the type of fluid. For example, it is presently believed that the specific impedance of at least some body fluids (i.e. the specific conductivity ρ(f) and the di-electric constant ∈(f)) in a frequency range between 10 MHz and 2000 MHz, more particularly between 20 MHz and 70 MHz and most particularly between 38 MHz and 58 MHz, is a function of the properties and concentration of the salty (ionic) components of the human body, related to variations in blood glucose. These salty components primarily include solvated sodium, potassium, calcium and other minor ions and their counter ions, the primary counter ion being chloride.
  • In one embodiment of the invention, only amplitude A0 is measured as a parameter for the determination of the concentration of the substance. Suitable calibration data stored in microprocessor 8 is used to convert amplitude A0 into the desired concentration level. In this example, the calibration data stored in microprocessor 8 is calibration data that is appropriate for the measurement of glucose in blood. In one embodiment, the calibration data includes an offset α0, a factor α1 for the relative amplitude and a factor α2 for the temperature correction. Thus, the resulting concentration equals α01*(measured impedance) +α2*temperature. Measurements of other types of targets, as described herein, may have their own respective types of calibration data.
  • In the example of measuring glucose levels in blood, the effects exploited for the measurement are temperature dependent. Temperature has an effect on permittivity and conductivity. Temperature appears to have a nonlinear effect on the measurement of impedance conducted in vivo with the current glucose monitoring device, that originates from nonlinear physiologic responses of the human body to temperatures conditions and changes. Changes in temperature have a more or less linear effect on ac conductivity per se. However, the human body reacts physiologically in a nonlinear way to changes in temperature. Thus, other embodiments of the invention take into account an appropriate temperature correction in applications where the target shows temperature dependence, e.g., nonlinear temperature dependence.
  • In order to obtain high accuracy over a wide temperature range, one brings temperature sensor 10 into thermal contact with the target. In the present example, the temperature sensor 10 does not need to be in physical contact with the target (i.e., blood or other liquid) being measured. Rather, the temperature sensor 10 can contact the skin to obtain temperature. The signals from temperature sensor 10 are used to correct the obtained result, again using calibration data obtained from calibration measurements.
  • A proper design of the electrodes of capacitor C permits optimization of the accuracy and sensitivity of the present device in a given application. Example geometry of a device suitable for taking in-vivo measurements in a living body is shown in FIGS. 2 and 3.
  • The device comprises a housing 13 closed on one side by an electrode plate 14. The display 11 is arranged opposite electrode plate 14. The electronic circuits 16 are arranged between electrode plate 14 and display 11.
  • Electrode plate 14 can include an electrically insulating substrate 17 with a sensor, e.g., a microstrip nearfield antenna having a microstrip electrode 18 and a top or ring/ground electrode 19 arranged on an outer side 20 thereof. A bottom electrode 22 covers an inner side 21 of insulating substrate 17. A plurality of through-contacts 23 is provided to connect ring/ground electrode 19 to bottom electrode 22. A further through-contact 24 connects one end of microstrip electrode 18 to a small bond pad 25 arranged in an opening 26 of bottom electrode 22 on inner side 21.
  • Temperature sensor 10 is mounted to bottom electrode 22. The large number of through-contacts 23 ensure that bottom electrode 22 follows the temperature of ring/ground electrode 18 and therefore the temperature of the target closely.
  • A typical size of electrode plate 14 is 32 mm ×21 mm. Bottom electrode 22 covers all of inner side 21 except for the small opening 26 and is therefore much larger than strip electrode 18.
  • Leads 28 are provided to connect bottom electrode 22, contact pad 26 and temperature sensor 10 to the electronic circuits 16.
  • While bottom electrode 22 and ring/ground electrode 19 are connected to ground, strip electrode 18 is connected to inductance L of resonant circuit 5. Therefore, the capacitor C is formed between strip electrode 18 as a first electrode and ring electrode 19 and bottom electrode 22 as a second electrode. In other words, the second electrode consists of two electrode layers: a top electrode layer formed by ring electrode 19 and a bottom electrode layer formed by bottom electrode 22.
  • An electrically insulating cover layer 29 covers all of strip electrode 18 but not ring electrode 19. In other words, strip electrode 18 is arranged between substrate 17 and cover layer 29. Cover layer 29 is preferably made of a hard, moisture- and salt-impervious material such as glass, ceramics, a polycarbonate or diamond-like carbon (DLC) of a thickness preferably between 50 and 100 μm.
  • FIGS. 2 and 3 illustrate a device that may be especially useful in applications where the device is to be disposed against a substantially flat surface, such as an area of skin on a living body. The geometry and orientation shown in FIGS. 2 and 3 are not limiting, however. Many different orientations, shapes, and sizes are usable in accordance with the invention. For example, the display 11 may be disposed along a side of the housing 13, or may be entirely separate from the housing 13 (e.g., in operable communication with the electronic circuits 16 but disposed at a location remote from the housing.)
  • In another embodiment, the display 11 and electronic circuits 16 are disposed within a first housing while the electrode plate 14 (or other configuration of electrodes) is disposed within a second housing, the electrodes being in operable communication with the electronic circuits 16. This configuration may be advantageous in embodiments of the invention that are used for applications and/or in environments that could cause damage and/or stress to the electronic circuits 16 and/or the display 11.
  • As can be seen in FIG. 4, a holder or wristband 31 is attached to housing 13 for fixing the device to an arm or a leg of a human body with cover layer 29 facing the body and a longitudinal axis of strip electrode 18 parallel to the arm or leg. In this way, ring electrode 19 comes into contact with the user's skin and the ring electrode and the area of the user's body in contact with the ring electrode come to a common reference potential.
  • As described above, a pure sine voltage has been found to be sufficient for the measurements. However, other types of modulated voltages, such as square-wave voltages or pulses can be used as well. In this case, measuring circuit 7 is preferably provided with suitable filters for selectively sampling one or more frequency components. At least one measured frequency component is preferably close to the resonance frequency of resonant circuit 5 for exploiting the circuit's high sensitivity to the target's properties at that frequency.
  • The electrode geometry can be varied for adapting it to a given application. While the design of FIG. 2 is optimized for a measurement on an arm or leg, a circular design can be used for measurement on a flatter body part or an in-vitro sample. Further, in embodiments of the invention that are used in the manufacturing, environmental, and/or agricultural industries, the electrode may have a geometry adapted for the given application, such as a partially-curved shape, a ring-like shape, a triangular shape, and a cylindrical shape. These other applications are described further herein.
  • Ring electrode 19 does not necessarily have to form a closed ring as long as it provides sufficient grounding of the site (e.g., in this example, the body part) to be measured. The ring electrode 19 can, e.g., also have a U-shape or consist of two stripes parallel to and laterally enclosing strip electrode 18. Ring electrode 19 can also be omitted completely or be covered by cover layer 29, especially for measurements (such as in-vitro measurements) where noise is low.
  • Part of one embodiment of an alternative embodiment of a circuit according to the invention is shown in FIG. 6. In FIG. 6, there is no direct wired connection between resonant circuit 5 and measuring circuit 7. Rather, an antenna electrode 33 is located in proximity to the electrodes of capacitor C, and measuring circuit 7 measures the signal returned by antenna electrode 33.
  • A possible arrangement of the electrodes for the circuit of FIG. 6 is shown in FIG. 7. As can be seen, antenna electrode 33 is strip shaped and arranged in parallel to strip electrode 18. Both, antenna electrode 33 and strip electrode 18 are covered by cover layer 29 and therefore electrically insulated from the target.
  • The device of FIGS. 6 and 7 is again sweeping VCO 1 between a frequency fmin below the resonance frequency f0 of resonant circuit 5 and a frequency fmax above it. In contrast to FIG. 5, measuring circuit 7 now detects a maximum amplitude A0 at f0, wherein the value of A0 depends on the response, i.e. the electrical properties of the target at the resonance frequency f0. Changing the resonant circuit to a tank circuit also changes the resonance curve in a way that a maximum rather then minimum amplitude results. The parameter AO can now again be processed using calibration data as described above.
  • A second embodiment of a circuit is shown in FIG. 8. Here, the capacitor C formed by the electrodes is part of the resonant tank circuit of an active, self-oscillating oscillator 40. The amplitude A and frequency fO of the output signal of oscillator 40 depend on the capacitance and losses in capacitor C. The corresponding signal is fed to measuring circuit 7, which evaluates the parameters A and f0. Measuring the corresponding parameters A and f0 again allows a sensitive measurement of the desired concentration using calibration data.
  • In the examples shown so far, the invention was used in a device for qualitatively or quantitatively displaying the concentration a substance (such as glucose) in body liquid. The invention can, however, also be used in devices that automatically administer medication to a body, such as an insulin pump, where the amount and/or time for administering the medication depends on the measured concentration of the substance in question. The invention can also be used in any other type of device that requires the measurement of the concentration of a substance in a target.
  • SECOND EXAMPLE APPLICATION Monitoring Concentrations of Substances During Biochemical Processes
  • Another aspect of the invention is directed to using the above-described device in other medical and/or biochemical applications, such as monitoring the concentrations of substances that can change electrical properties of the target such as sodium during biochemical processes. Biochemical processing is essential to many food, chemical, and pharmaceutical industries. At least one embodiment of the invention is directed to an application of the above-described device that is suitable for serving as a measuring device for defined levels of a substance in a liquid during a biochemical process in a bioreactor.
  • One example of a biochemical process for which the invention may be used is in connection with a fermenter. Fermentation is one typical biochemical process that may be used in the production of products such as organic acids or dairy products. The fermenter is an important part of an ethanol production process. Ethanol may be produced in a fermenter during the biodegradation of glucose by yeast. After sterilizing, the glucose solution is fed to a fermenter. Nutrients to support cell growth may also be provided.
  • The production of a chemical such as ethanol may be monitored to improve the efficiency of the process. One way this can be accomplished using the present invention is by providing a fermenter with an online sensor or a plurality of online sensors constructed and arranged to track a concentration of product(s) during the fermenting process. Impedance spectroscopy techniques according to embodiments of the invention can use data provided by these sensors to provide a non-invasive and online way to monitor alcohol production.
  • More generally, with reference to FIG. 9, an initial process 50 can produce product that is then transported 52 to a new location. The product is then pumped into fermenter 54. A valve 56 controls flow of the product. A sensor 58 monitors the concentration of a substance of interest in the product. Elements 60 and 62 perform a second process on the product. Sensor 64 monitors the concentration of a substance of interest during the second process and sensor 66 monitors the concentration of a substance of interest in the waste flow from the second process. In one embodiment, one or more of the sensors can provide data to a control on the valve to allow the control to manage the valve based at least in part on the sensor data. For example, if the concentration of a substance of interest goes too high, the valve control may shut the valve.
  • In addition, the devices and methods as applied to the monitoring of fermentation may also be applicable to monitoring the manufacture and processing of brewed and/or fermented beverages, such as beer, in a substantially similar manner to that described above.
  • FIGS. 10A-F show various configurations of systems for monitoring processes as described above. With reference to FIG. 10A, a pipe 70 is transporting product, e.g., wastewater, and a sensor 72 is mounted to the pipe 70. With reference to FIG. 10B, the sensor 72 is shown in greater detail mounted onto/into a pipe. In one embodiment, the configuration of the sensor 72 is a shown in FIGS. 2 and 3. With reference to FIG. 10C, an interior section of the pipe shows the microstrip 18 and the ring electrode 19, the ground is actually in touch with the target, i.e., the product. Yet the microstrip can be electrically insulated from the target. FIGS. 10D and E show the same configuration with the sensor providing data to a valve control 76 associated with a valve 74 in the pipe 70. Thus, the sensor 72 provides data, e.g., concentration measurements of a substance of interest, to a control element 76 , e.g., a valve controller other process controller. In the valve control embodiment, the valve control manages, e.g., closes, the valve based at least in part on the sensor data.
  • Finally, with reference to FIG. 10F, a fermentor 78 having an input pipe 80 can have a sensor 72 mounted on it. The sensor can monitor the progress of a reaction. The fermenter can brew a product where electrolyte concentration is changing, or the fermenter can brew beer where the concentration of a substance of interest is monitored.
  • THIRD EXAMPLE APPLICATION Detecting changes in Body Tissue
  • Inflammatory processes in the body have a characteristic impact on the impedance pattern of living tissue (in both humans and animals). Thus, in at least one embodiment, the devices and methods of the invention may be applied to diagnose changes in tissue, such as those resulting from inflammatory processes in the body, cancer, and edemas.
  • Edemas are accumulations of water in tissues (although water in cells and serous cavities also may be considered to be edemas as well). These accumulations of water show a significantly different impedance pattern compared to that of healthy tissue. Using devices and methods such as those described herein, at least superficial edemas could be discriminated from normal tissue, in a non-invasive, quick, inexpensive, and relatively pain-free manner.
  • Thus, one can use an embodiment of a device according to the invention to detect edemas by sizing the housing and the electrodes to fit over the area of the body being measured.
  • Furthermore, certain electrical properties of tumor cells differ from those of the normal tissues that surround them. Tumor cells demonstrate greater permittivity (ability to resist the formation of an electrical field) and conductivity of electrical current. These findings are thought to occur because (a) cancer cells tend to have higher sodium and water content than normal cells, and (b) their cell membranes have different electrochemical properties. Thus, the devices and methods of the invention could be applied to detect other types of changes in the tissue of a body, especially changes detectable near the surface of the skin, such as skin cancer, breast cancer, and some types of tumors.
  • FOURTH EXAMPLE APPLICATION Determining Conditions of Cells During Processing
  • During various types of processes (such as biochemical processes, and growth of cell cultures), batches of cells sometimes produce low yields because of partly damaged cells, e.g., damaged cell walls or membranes. It can be difficult to evaluate the presence or extent of this type of damage prior to the start of a process. However, impedance spectroscopy techniques, such as those techniques used in the devices and methods of the invention, may be used to assess the quality of a given cell before a process moves to the next production step.
  • It is believed that a cell and its surrounding environment can act like a simple circuit having characteristic impedance. The cell cytoplasm and the extracellular space (which has a conductivity) comprise resistive components of the impedance. The cell membrane itself contributes capacitive effects to the impedance, especially as the frequency to which the cell is subjected is increased. By characterizing “high quality cells” at a given frequency range, it is possible to use the systems and methods of the invention to monitor cells to determine their condition relative to the. “high quality cells”. For example, changes in impedance may reflect deviations from normal in the cell membrane. This may also be done with cells in suspension.
  • FIFTH EXAMPLE APPLICATION Monitoring Concentrations of Substances in Infusions
  • At least one aspect of the invention is directed to an application of the above-described device that is suitable for tracking concentrations of substances in infusions. For example, the devices and methods of the invention can be applied for monitoring solutions in medical use, such as sodium, potassium, or other salt solutions, to ensure constant flux and concentration. A standard Sodium Chloride infusion given to a patient basically involves three risks:
      • a) is it really NaCl and not KCl
      • b) is it the correct concentration
      • c) is it still running (drift of the rate of infusion)
  • The above issues are particularly interesting for prenatal care units. Thus, embodiments of the present invention can be utilized to verify concentrations and operation at the point of delivery.
  • SIXTH EXAMPLE APPLICATION Monitoring the Production of Foodstuffs
  • Use of the invention in the growth and/or production of food and/or beverages can help to ensure the quality and safety of the resulting products and can also save time in the growth and/or production process. Examples of use of embodiments of the invention in such processes are shown in FIGS. 9-10F.
  • For example, at least one aspect of the invention is directed to an application of the above-described device that is suitable for testing foods and beverages, both during growth and during processing. In this aspect, the invention is used to monitor the concentration of a substance (e.g., water and sodium chloride) in a food and/or beverage product being produced, such as baby food, dairy products, beer, or wine. During growth or preparation of the food product, the pair of electrodes of the device could be disposed on the surface of the food product, to detect the concentration of a given substance (e.g., sodium) in the food product.
  • In one embodiment, the devices and methods of the invention are applied to monitor wine processing. The quality of wine is said to depend on a few parameters, one of which is the electrolyte balance and alcohol content. As with the fermentation process described previously, the invention is used to monitor the transformation of glucose into alcohol, so that the process can be stopped when glucose concentration reaches a predetermined level.
  • In another example, at least one aspect of the invention is directed to an application of the above-described device that is suitable for monitoring water concentration in food and/or beverage products. Monitoring water concentration may be especially useful in improving the timing and efficiency of dairy processes such as the making of butter or cheese, where the water content may have significant impact on the quality of the resulting product.
  • In another example, at least one aspect of the invention is directed to an application of the above-described device that is suitable for measuring the concentration of water and/or electrolytes in an agricultural product.
  • SEVENTH EXAMPLE APPLICATION Wastewater Analysis
  • Because the devices and methods of the invention can be used to detect changes in water composition, in at least one embodiment the devices and methods of the invention have use in applications such as analysis of wastewater. For example, an accident or error occurring during production at a chemical plant could result in harmful compounds contaminating drainage water exiting the chemical plant. The devices and methods of the invention provide an inexpensive, sensitive method to monitor the exiting wastewater for this kind of occurrence. The device according to the invention may be coupled to trigger an alarm when certain predetermined changes in water composition occur.
  • Further, the devices and methods of the invention may be used throughout the chemical process (e.g., monitoring the status and progress of chemical processes, as described previously for the “biochemical processes” application). Examples of use of embodiments of the invention in such processes are shown in FIGS. 10-11F.
  • EIGHTH EXAMPLE APPLICATION Corrosion Testing
  • The methods and devices of the invention, which use RF impedance spectroscopy, are usable to characterize and measure corrosion. One example of a technique for characterizing corrosion is described in U.S. Pat. No. 4,238,298, incorporated herein by reference in its entirety. Passing an alternating current (A.C.) at a high frequency between two electrodes disposed in a corrosion medium will give the ohmic resistance of the corrosion medium. Passing an AC current at a low frequency between the electrodes gives an impedance that is equal to the sum of the ohmic resistance and the corrosion reaction resistance. The corrosion reaction resistance is inversely proportional to the corrosion rate of the metal in the medium.
  • The devices and methods of the invention can be adapted to measure the ohmic impedance and the corrosion reaction impedances, as described above, at both low and high frequencies. It is then possible to compute the reciprocal of the difference between the ohmic impedance and the corrosion reaction impedance, to give the corrosion rate.
  • NINTH EXAMPLE APPLICATION Measuring Salt in Street Water
  • Because the methods and devices of the present invention detect the concentration of solutes such as salts in an aqueous solution, one application of the invention is for determining whether a surface (such as a street) coated with water has been treated with a substance such as road salt.
  • For example, the invention can be used in an automobile, to detect whether a road or street has been salted (such as when it snows). The invention is used in connection with a sensor head located to measure the salt content of the water splashing up from the wheels.
  • TENTH EXAMPLE APPLICATION Environmental Monitoring
  • Waters around industries and ecologically sensitive areas needs to be closely monitored to ensure purity and water quality. The devices and methods of the invention provide a simple, inexpensive way to monitor the quality of the water by monitoring the concentration of water and/or concentration of one or more substances in the water.
  • While there are shown and described presently preferred embodiments of the invention, it is to be distinctly understood that the invention is not limited thereto but may be otherwise variously embodied and practiced within the scope this disclosure.

Claims (31)

  1. 1. A system for controlling a process involving a specimen, the system comprising:
    a first electrode covered by a cover layer of insulating material and adapted to receive a modulated electrical voltage for generating an electric field in the specimen;
    a measuring circuit for measuring at least one parameter depending on a response of the specimen to the field;
    a data processor section connected to the measuring circuit and operative to determine a concentration of a substance in the specimen from the parameter and to out-put data in response to the determined concentration; and
    a control circuit connected to the data processor section and operative to receive data from the data processor section and to control an aspect of the process based at least in part on the data from the data processor.
  2. 2. The system of claim 1 wherein the control means comprises:
    a valve control adapted for controlling a valve based at least in part on the concentration data.
  3. 3. The system of claim 1 wherein the data from the data processor section is concentration data.
  4. 4. The system of claim 1 wherein the system further comprises:
    an electrically insulating substrate, wherein the first electrode is arranged on a first side of the substrate between the substrate and the cover layer.
  5. 5. The system of claim 4 further comprising a second electrode arranged on the substrate, and wherein the first and second electrodes are adapted to generate a modulated field between the electrodes in response to the modulated electric voltage..
  6. 6. The system of claim 5, wherein the second electrode comprises a bottom electrode layer arranged on a second side of the substrate, the bottom electrode layer having a larger extension than the first electrode.
  7. 7. The system of claim 6 wherein the second electrode comprises a top electrode layer arranged on the first side of the substrate, the top electrode layer being arranged around at least part of the first electrode.
  8. 8. The system of claim 7 wherein the system further comprises:
    first and second signal paths between the signal source and the measuring circuit, wherein the first electrode is arranged in the first signal path and a reference load is arranged in the second signal path, and wherein the measuring circuit is adapted to measure at least one of a relative amplitude (A) and a phase (phi) of signals from the first and second paths.
  9. 9. The system of claim 8 wherein the first electrode is part of a capacitor of a resonant circuit comprising
    the capacitor and an inductance, the resonant circuit being connected to the signal source.
  10. 10. The system of claim 9 wherein the capacitor and the inductance are arranged in series.
  11. 11. The system of claim 9 wherein the system further comprises an antenna electrode arranged in proximity to the first electrode and wherein the measuring circuit is adapted to measure a signal transmitted from the first electrode to the antenna electrode.
  12. 12. A method for managing a process involving a specimen, the method comprising:
    arranging a first electrode at the specimen, wherein the first electrode is electrically insulated from the specimen;
    receiving a modulated electrical voltage signal at the first electrode to generate a modulated field in the specimen;
    measuring at least one parameter depending on a response of the specimen to the field;
    determining a concentration of a substance in the specimen based at least in part on the measured parameter; and
    controlling an aspect of the process based at least in part on the determined concentration.
  13. 13. The method of claim 12 wherein controlling an aspect of the process comprises controlling a valve based at least in part on the determined concentration.
  14. 14. The method of claim 12 wherein the method further comprises arranging a second electrode at the specimen and wherein the modulated electrical voltage generates a modulated field between the first and the second electrode.
  15. 15. The method of claim 14 wherein the second electrode is in electric contact with the specimen.
  16. 16. The method of claim 14 wherein the method further comprises measuring a temperature of the specimen and using the temperature in the determination of the concentration.
  17. 17. The method of claim 12 wherein the modulated electrical voltage signal is a sine wave.
  18. 18. The method of claim 17 wherein the modulated electrical voltage signal has a frequency between 10 MHz and 2 GHz.
  19. 19. The method of claim 12 wherein the method further comprises arranging an antenna electrode at the specimen in proximity to the first electrode and wherein the response of the specimen is measured by measuring a signal transmitted from the first electrode to the antenna electrode.
  20. 20. The method of claim 12 wherein the substance is glucose.
  21. 21. The method of claim 12 wherein the specimen is a living body.
  22. 22. The method of claim 12 wherein the determining the concentration comprises using calibration data to convert the parameter to the concentration.
  23. 23. The method of claim 12 wherein the first electrode forms part of a resonant circuit having a resonance frequency and wherein the resonant circuit is operated substantially at the resonance frequency.
  24. 24. The method of claim 23 wherein the resonant circuit is at least part of a tank circuit of an active oscillator and wherein the parameter is one of an amplitude and a frequency of a signal generated by the oscillator.
  25. 25. The method of claim 12 wherein receiving a modulated voltage comprises receiving a frequency sweeped modulated voltage wherein the frequency is swept from a frequency below the resonance frequency to a frequency above the resonance frequency.
  26. 26. The method of claim 12 wherein the substance is an alcohol.
  27. 27. The method of claim 12 wherein the specimen is a salt solution.
  28. 28. The method of claim 12 wherein the substance is a salt.
  29. 29. A method for obtaining an indication of a condition of a specimen, the method comprising:
    arranging a first electrode at the specimen, wherein the first electrode is electrically insulated from the specimen;
    receiving a modulated electrical voltage signal at the first electrode to generate a modulated field in the specimen;
    measuring at least one parameter depending on a response of the specimen to the field;
    determining an impedance of the specimen based at least in part on the measured parameter; and
    determining whether an indication of a condition exists based at least in part on the impedence of the specimen.
  30. 30. The method of claim 29 wherein the determining whether an indication of a condition exists comprises using calibration data.
  31. 31. The method of claim 29 wherein the condition is edema.
US10656997 2001-03-06 2003-09-05 Impedance spectroscopy based systems and methods Expired - Fee Related US7315767B2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
US09980661 US7693561B2 (en) 2001-03-06 2001-03-06 Method and device for determining the concentration of a substance in body liquid
PCT/IB2001/000334 WO2002069791A1 (en) 2001-03-06 2001-03-06 Method and device for determining the concentration of a substance in body liquid
US40837702 true 2002-09-05 2002-09-05
US10656997 US7315767B2 (en) 2001-03-06 2003-09-05 Impedance spectroscopy based systems and methods

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10656997 US7315767B2 (en) 2001-03-06 2003-09-05 Impedance spectroscopy based systems and methods

Related Parent Applications (3)

Application Number Title Priority Date Filing Date
US09980661 Continuation-In-Part
US09980661 Continuation-In-Part US7693561B2 (en) 2001-03-06 2001-03-06 Method and device for determining the concentration of a substance in body liquid
PCT/IB2001/000334 Continuation-In-Part WO2002069791A1 (en) 2001-03-06 2001-03-06 Method and device for determining the concentration of a substance in body liquid

Publications (3)

Publication Number Publication Date
US20040147819A1 true US20040147819A1 (en) 2004-07-29
US20060004269A9 true true US20060004269A9 (en) 2006-01-05
US7315767B2 US7315767B2 (en) 2008-01-01

Family

ID=32738052

Family Applications (1)

Application Number Title Priority Date Filing Date
US10656997 Expired - Fee Related US7315767B2 (en) 2001-03-06 2003-09-05 Impedance spectroscopy based systems and methods

Country Status (1)

Country Link
US (1) US7315767B2 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012011066A1 (en) * 2010-07-21 2012-01-26 Kyma Medical Technologies Ltd. Implantable dielectrometer
WO2015175654A1 (en) * 2014-05-13 2015-11-19 Auburn University Capacitive fringing field sensors and electrical conductivity sensors integrated into printed circuit boards
US20160007891A1 (en) * 2004-02-05 2016-01-14 Dermal Devices Inc. Method and Apparatus for Measuring Glucose in Body Fluids Using Sub-Dermal Body Tissue Impedance Measurements
DE102014014071A1 (en) * 2014-09-29 2016-03-31 Trw Automotive Gmbh Vehicle operating element as well as methods for the noninvasive measurement of biomolecules

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1818010B1 (en) 2001-03-06 2012-02-29 Solianis Holding AG Device for determining the concentration of a substance in body liquid
US7315767B2 (en) * 2001-03-06 2008-01-01 Solianis Holding Ag Impedance spectroscopy based systems and methods
WO2004021877A9 (en) * 2002-09-04 2006-11-02 Pendragon Medical Ltd Method and device for measuring glucose
DE60230824D1 (en) * 2002-09-24 2009-02-26 Solianis Holding Ag Device for measurement of glucose concentrations
US8886273B2 (en) * 2003-08-01 2014-11-11 Dexcom, Inc. Analyte sensor
US8886272B2 (en) 2004-07-13 2014-11-11 Dexcom, Inc. Analyte sensor
US8626257B2 (en) * 2003-08-01 2014-01-07 Dexcom, Inc. Analyte sensor
WO2005053526A1 (en) * 2003-11-27 2005-06-16 Solianis Holding Ag Techniques for determining glucose levels
EP1694197B1 (en) * 2003-12-02 2011-11-02 Solianis Holding AG A device and method for measuring a property of living tissue
US8425417B2 (en) * 2003-12-05 2013-04-23 Dexcom, Inc. Integrated device for continuous in vivo analyte detection and simultaneous control of an infusion device
US20080197024A1 (en) * 2003-12-05 2008-08-21 Dexcom, Inc. Analyte sensor
US8287453B2 (en) * 2003-12-05 2012-10-16 Dexcom, Inc. Analyte sensor
EP1706028A1 (en) * 2004-01-19 2006-10-04 Teca S.r.l. Product for measuring the effectiveness and efficiency of warming-up and winding-down physical exercises and training equipment comprising said product
US8200307B2 (en) * 2004-06-07 2012-06-12 Biovotion Ag Method and device for determining a parameter of living tissue
US7783333B2 (en) 2004-07-13 2010-08-24 Dexcom, Inc. Transcutaneous medical device with variable stiffness
JP4947440B2 (en) * 2005-11-10 2012-06-06 バイオボーション・アーゲーBiovotion AG Apparatus for determining the glucose level in the body tissue
KR100726309B1 (en) * 2005-12-30 2007-06-01 주식회사 릿치마이크로웨이브 Apparatus for measuring blood sugar and apparatus for monitoring blood sugar comprising the same
US8133178B2 (en) 2006-02-22 2012-03-13 Dexcom, Inc. Analyte sensor
US8323189B2 (en) 2006-05-12 2012-12-04 Bao Tran Health monitoring appliance
US9865176B2 (en) 2012-12-07 2018-01-09 Koninklijke Philips N.V. Health monitoring system
US9060683B2 (en) 2006-05-12 2015-06-23 Bao Tran Mobile wireless appliance
US8968195B2 (en) 2006-05-12 2015-03-03 Bao Tran Health monitoring appliance
US7539533B2 (en) 2006-05-16 2009-05-26 Bao Tran Mesh network monitoring appliance
US7558622B2 (en) * 2006-05-24 2009-07-07 Bao Tran Mesh network stroke monitoring appliance
US8364230B2 (en) 2006-10-04 2013-01-29 Dexcom, Inc. Analyte sensor
US8532730B2 (en) 2006-10-04 2013-09-10 Dexcom, Inc. Analyte sensor
US8298142B2 (en) * 2006-10-04 2012-10-30 Dexcom, Inc. Analyte sensor
US8562528B2 (en) * 2006-10-04 2013-10-22 Dexcom, Inc. Analyte sensor
US8447376B2 (en) 2006-10-04 2013-05-21 Dexcom, Inc. Analyte sensor
US8449464B2 (en) * 2006-10-04 2013-05-28 Dexcom, Inc. Analyte sensor
US8275438B2 (en) * 2006-10-04 2012-09-25 Dexcom, Inc. Analyte sensor
US8478377B2 (en) * 2006-10-04 2013-07-02 Dexcom, Inc. Analyte sensor
US8364231B2 (en) 2006-10-04 2013-01-29 Dexcom, Inc. Analyte sensor
US8425416B2 (en) 2006-10-04 2013-04-23 Dexcom, Inc. Analyte sensor
EP2152350A4 (en) 2007-06-08 2013-03-27 Dexcom Inc Integrated medicament delivery device for use with continuous analyte sensor
US8647272B2 (en) * 2007-06-21 2014-02-11 Rf Science & Technology Inc Non-invasive scanning apparatuses
US8259299B2 (en) 2007-06-21 2012-09-04 Rf Science & Technology Inc. Gas scanning and analysis
US8382668B2 (en) * 2007-06-21 2013-02-26 Rf Science & Technology Inc. Non-invasive determination of characteristics of a sample
US20080319293A1 (en) * 2007-06-21 2008-12-25 Pindi Products, Inc. Sample scanning and analysis system and methods for using the same
US8647273B2 (en) * 2007-06-21 2014-02-11 RF Science & Technology, Inc. Non-invasive weight and performance management
CA2715628A1 (en) * 2008-02-21 2009-08-27 Dexcom, Inc. Systems and methods for processing, transmitting and displaying sensor data
WO2009114115A1 (en) * 2008-03-10 2009-09-17 S.E.A. Medical Systems, Inc. Intravenous fluid monitoring
US8396528B2 (en) * 2008-03-25 2013-03-12 Dexcom, Inc. Analyte sensor
US9307935B2 (en) 2008-10-27 2016-04-12 Biosensors, Inc. Non-invasive monitoring of blood metabolite levels
US20090270756A1 (en) * 2008-04-23 2009-10-29 Gamache Ronald W Determining physiological characteristics of animal
US20110160554A1 (en) * 2008-06-18 2011-06-30 Alexander Megej Device and method for determining at least one characterizing parameter of multilayer body tissue
US20110199097A1 (en) * 2008-10-22 2011-08-18 Larry Dowd Hartsough Sensor system with reduced sensitivity to sample placement
US8653830B2 (en) * 2008-12-02 2014-02-18 Ut-Battelle, Llc Optically stimulated differential impedance spectroscopy
JP5623504B2 (en) 2009-04-17 2014-11-12 バイオボーション・アーゲーBiovotion AG Sensing device of the characteristics of the body tissue
US9052276B2 (en) 2009-06-08 2015-06-09 S.E.A. Medical Systems, Inc. Systems and methods for the identification of compounds using admittance spectroscopy
CN102460137A (en) * 2009-06-08 2012-05-16 S.E.A.医疗系统公司 Systems and methods for the identification of compounds in medical fluids using admittance spectroscopy
KR101688918B1 (en) * 2010-05-08 2016-12-22 더 리전트 오브 더 유니버시티 오브 캘리포니아 Sem scanner sensing apparatus, system and methodology for early detection of ulcers
CN103501839A (en) 2010-09-09 2014-01-08 S.E.A.医疗系统公司 Systems and methods for intravenous drug management using immittance spectroscopy
CN103282764A (en) * 2010-10-29 2013-09-04 尼尔科学公司 Method and apparatus for analyte detection
WO2012142536A3 (en) * 2011-04-14 2013-01-10 Bayer Healthcare Llc Detection of contamination at sensor contacts
US9801575B2 (en) 2011-04-15 2017-10-31 Dexcom, Inc. Advanced analyte sensor calibration and error detection
KR20130059997A (en) 2011-11-29 2013-06-07 한국전자통신연구원 Method for optical constant measurement and apparatus thereof
EP2825096A1 (en) 2012-03-16 2015-01-21 Dexcom, Inc. Systems and methods for processing analyte sensor data
WO2014048799A3 (en) 2012-09-25 2014-07-31 Sony Corporation Measurement of the permittivity of a liquid using an interferometric microstrip bridge comprising a parallel coupled line filter with the liquid under test/a reference liquid as overlay in the measurement/reference paths
US9274071B2 (en) 2013-12-30 2016-03-01 General Electric Company Methods for assessing cell culture fluid by impedance spectra
GB201602773D0 (en) * 2016-02-17 2016-03-30 Orsus Medical Ltd A method and apparatus for measuring the concentration of target substances in blood

Citations (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4020830A (en) * 1975-03-12 1977-05-03 The University Of Utah Selective chemical sensitive FET transducers
US4180771A (en) * 1977-12-02 1979-12-25 Airco, Inc. Chemical-sensitive field-effect transistor
US4397714A (en) * 1980-06-16 1983-08-09 University Of Utah System for measuring the concentration of chemical substances
US4445885A (en) * 1977-02-16 1984-05-01 Unitika, Ltd. Insulin releasing supplier
US4509531A (en) * 1982-07-28 1985-04-09 Teledyne Industries, Inc. Personal physiological monitor
US4679426A (en) * 1985-09-09 1987-07-14 Fuller Milton E Wave shape chemical analysis apparatus and method
US4765179A (en) * 1985-09-09 1988-08-23 Solid State Farms, Inc. Radio frequency spectroscopy apparatus and method using multiple frequency waveforms
US4875486A (en) * 1986-09-04 1989-10-24 Advanced Techtronics, Inc. Instrument and method for non-invasive in vivo testing for body fluid constituents
US4965206A (en) * 1986-09-22 1990-10-23 Kell Douglas B Determination of biomass
US5050612A (en) * 1989-09-12 1991-09-24 Matsumura Kenneth N Device for computer-assisted monitoring of the body
US5077476A (en) * 1990-06-27 1991-12-31 Futrex, Inc. Instrument for non-invasive measurement of blood glucose
US5109855A (en) * 1986-07-14 1992-05-05 Handelsgesellschaft Fur Medizin Und Technik Mit Beschrankter Haftung Apparatus for detecting properties, differences and changes of human animal bodies
US5353802A (en) * 1990-10-18 1994-10-11 Centrum For Dentalteknik Och Biomaterial Device for measurement of electrical impedance of organic and biological materials
US5508203A (en) * 1993-08-06 1996-04-16 Fuller; Milton E. Apparatus and method for radio frequency spectroscopy using spectral analysis
US5771891A (en) * 1995-05-10 1998-06-30 Massachusetts Inst Technology Apparatus and method for non-invasive blood analyte measurement
US5792668A (en) * 1993-08-06 1998-08-11 Solid State Farms, Inc. Radio frequency spectral analysis for in-vitro or in-vivo environments
US5804967A (en) * 1996-11-15 1998-09-08 The United States Of America As Represented By The Secretary Of The Navy Apparatus and method for generating short pulses for NMR and NQR processing
US5890489A (en) * 1996-04-23 1999-04-06 Dermal Therapy (Barbados) Inc. Method for non-invasive determination of glucose in body fluids
US6028433A (en) * 1997-05-14 2000-02-22 Reid Asset Management Company Portable fluid screening device and method
US6182504B1 (en) * 1997-11-03 2001-02-06 Roxar, Inc. Emulsion composition monitor
US6309884B1 (en) * 1997-02-26 2001-10-30 Diasense, Inc. Individual calibration of blood glucose for supporting noninvasive self-monitoring blood glucose
US6320393B1 (en) * 1998-10-20 2001-11-20 Mitsubishi Denki Kabushiki Kaisha Fluid dielectric constant sensing device and method employing the same
US6356776B1 (en) * 1998-05-13 2002-03-12 Cygnus, Inc. Device for monitoring of physiological analytes
US20020155615A1 (en) * 2001-02-05 2002-10-24 Novikov Igor A. Method of determining concentration of glucose in blood
US6517482B1 (en) * 1996-04-23 2003-02-11 Dermal Therapy (Barbados) Inc. Method and apparatus for non-invasive determination of glucose in body fluids
US6565509B1 (en) * 1998-04-30 2003-05-20 Therasense, Inc. Analyte monitoring device and methods of use
US6723048B2 (en) * 1999-12-28 2004-04-20 Pindi Products, Inc. Method and apparatus for non-invasive analysis of blood glucose
US20040104736A1 (en) * 2001-03-13 2004-06-03 Emanuel Cohen Apparatus and method for analysing fluids
US20040133353A1 (en) * 2001-04-12 2004-07-08 Geutebrueck Ernst Method and device for detecting functional and metabolic data of a living organism
US20040147819A1 (en) * 2001-03-06 2004-07-29 Andreas Caduff Impedance spectroscopy based systems and methods
US20040240512A1 (en) * 2001-06-21 2004-12-02 Benny Pesach Permittivity based temperature measurement and related methods
US20050101842A1 (en) * 2002-09-20 2005-05-12 Nihon Seimitsu Sokki Co., Ltd. Electronic device for health index measurement and control method of the same
US20050113662A1 (en) * 2001-04-27 2005-05-26 Nasr-Eddine Djennati Emanuel Cohen Magnetic sensor and method for analysing a fluid
US6954662B2 (en) * 2003-08-19 2005-10-11 A.D. Integrity Applications, Ltd. Method of monitoring glucose level

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2387659B1 (en) 1977-04-21 1984-03-09 Armines
GB2033575B (en) 1978-05-24 1983-03-02 Rolfe P Investigating substances in a patient's bloodstream
GB2100864B (en) 1978-05-24 1983-06-02 Peter Rolfe Investigating substances in bloodstream and detecting blood flow
GB2055206B (en) 1979-07-31 1983-11-16 Yeda Res & Dev Detection of tumors
DE3017168C2 (en) 1980-05-05 1989-08-31 Yeda Research And Development Co., Ltd., Rehovot, Il
GB8408529D0 (en) 1984-04-03 1984-05-16 Health Lab Service Board Concentration of biological particles
EP0298441B1 (en) 1987-07-06 1993-10-27 Handelsgesellschaft Für Medizin Und Technik Mit Beschränkter Haftung Device for the determination of characteristics, differences and changes in the human or animal body
US4751476A (en) 1987-09-21 1988-06-14 Fisher Scientific Company Detector device and method for distinguishing between fluids having different dielectric properties
WO1993018395A1 (en) 1992-03-10 1993-09-16 Christopher Barnes Apparatus for determining the physical and/or chemical properties of a sample, particularly of blood
GB9204689D0 (en) 1992-03-04 1992-04-15 Univ Wales Analytical method & apparatus
RU2069863C1 (en) 1992-06-18 1996-11-27 Центральный научно-исследовательский институт машиностроения Analyzer of gas, liquid and loose media
RU2073242C1 (en) 1993-01-01 1997-02-10 Виктор Иванович Леднев Method for indication of sugar content in blood and device for its embodiment
RU2088927C1 (en) 1993-04-01 1997-08-27 Ламбров Владимир Васильевич Method and device for controlling sugar quantity in human blood in cases of diabetes mellitus
DE4446346A1 (en) 1994-12-23 1996-06-27 Ulrich Dr Warnke Detecting volume changes of electrolytes esp. blood or lymph fluid in living body parts
EP0966664B1 (en) 1996-09-09 2004-05-12 Xoetronics, LLC Photonic molecular probe
GB9704737D0 (en) 1997-03-07 1997-04-23 Optel Instr Limited Biological measurement system
WO1999039627A1 (en) 1998-02-04 1999-08-12 Dermal Therapy (Barbados) Inc. Method and apparatus for non-invasive determination of glucose in body fluids
WO1999044495A1 (en) 1998-03-02 1999-09-10 Conarma Ab A device for the determination of blood sugar
DE69914319D1 (en) 1998-05-13 2004-02-26 Cygnus Therapeutic Systems Signal processing for measurement of physiological analytes
WO2000009996A9 (en) 1998-08-10 2000-08-03 Solid State Farms Inc Improving radio frequency spectral analysis for in-vitro or in-vivo environments
GB9901304D0 (en) 1999-01-22 1999-03-10 Univ Liverpool Apparatus and method for determining dielectric properties of an electrically conductive fluid
EP1092386A1 (en) 1999-10-13 2001-04-18 Süsstrunk Anita Method and device for determining the concentration of a substance in blood
FI111298B (en) 1999-11-16 2003-06-30 Delfin Technologies Ltd A method for measuring skin moisture, and the application process unit
DE10035415A1 (en) 2000-07-20 2002-01-31 Precisa Technologies Ltd Ag Zu Non-invasive determination of blood sugar comprises applying electric field to blood sample, switching off field, evaluating change in dielectric polarization of molecules with time and calculating the concentration of substance
EP1309271B1 (en) 2000-08-18 2008-04-16 Animas Technologies LLC Device for prediction of hypoglycemic events
EP1818010B1 (en) 2001-03-06 2012-02-29 Solianis Holding AG Device for determining the concentration of a substance in body liquid
EP1427332A1 (en) 2001-08-24 2004-06-16 Glucosens, Inc. Biological signal sensor and device for recording biological signals incorporating the said sensor

Patent Citations (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4020830A (en) * 1975-03-12 1977-05-03 The University Of Utah Selective chemical sensitive FET transducers
US4020830B1 (en) * 1975-03-12 1984-09-04
US4445885A (en) * 1977-02-16 1984-05-01 Unitika, Ltd. Insulin releasing supplier
US4180771A (en) * 1977-12-02 1979-12-25 Airco, Inc. Chemical-sensitive field-effect transistor
US4397714A (en) * 1980-06-16 1983-08-09 University Of Utah System for measuring the concentration of chemical substances
US4509531A (en) * 1982-07-28 1985-04-09 Teledyne Industries, Inc. Personal physiological monitor
US4679426A (en) * 1985-09-09 1987-07-14 Fuller Milton E Wave shape chemical analysis apparatus and method
US4765179A (en) * 1985-09-09 1988-08-23 Solid State Farms, Inc. Radio frequency spectroscopy apparatus and method using multiple frequency waveforms
US5109855A (en) * 1986-07-14 1992-05-05 Handelsgesellschaft Fur Medizin Und Technik Mit Beschrankter Haftung Apparatus for detecting properties, differences and changes of human animal bodies
US4875486A (en) * 1986-09-04 1989-10-24 Advanced Techtronics, Inc. Instrument and method for non-invasive in vivo testing for body fluid constituents
US4965206A (en) * 1986-09-22 1990-10-23 Kell Douglas B Determination of biomass
US5050612A (en) * 1989-09-12 1991-09-24 Matsumura Kenneth N Device for computer-assisted monitoring of the body
US5077476A (en) * 1990-06-27 1991-12-31 Futrex, Inc. Instrument for non-invasive measurement of blood glucose
US5353802A (en) * 1990-10-18 1994-10-11 Centrum For Dentalteknik Och Biomaterial Device for measurement of electrical impedance of organic and biological materials
US5508203A (en) * 1993-08-06 1996-04-16 Fuller; Milton E. Apparatus and method for radio frequency spectroscopy using spectral analysis
US5792668A (en) * 1993-08-06 1998-08-11 Solid State Farms, Inc. Radio frequency spectral analysis for in-vitro or in-vivo environments
US5771891A (en) * 1995-05-10 1998-06-30 Massachusetts Inst Technology Apparatus and method for non-invasive blood analyte measurement
US6517482B1 (en) * 1996-04-23 2003-02-11 Dermal Therapy (Barbados) Inc. Method and apparatus for non-invasive determination of glucose in body fluids
US5890489A (en) * 1996-04-23 1999-04-06 Dermal Therapy (Barbados) Inc. Method for non-invasive determination of glucose in body fluids
US5804967A (en) * 1996-11-15 1998-09-08 The United States Of America As Represented By The Secretary Of The Navy Apparatus and method for generating short pulses for NMR and NQR processing
US6309884B1 (en) * 1997-02-26 2001-10-30 Diasense, Inc. Individual calibration of blood glucose for supporting noninvasive self-monitoring blood glucose
US6028433A (en) * 1997-05-14 2000-02-22 Reid Asset Management Company Portable fluid screening device and method
US6182504B1 (en) * 1997-11-03 2001-02-06 Roxar, Inc. Emulsion composition monitor
US6565509B1 (en) * 1998-04-30 2003-05-20 Therasense, Inc. Analyte monitoring device and methods of use
US6356776B1 (en) * 1998-05-13 2002-03-12 Cygnus, Inc. Device for monitoring of physiological analytes
US6320393B1 (en) * 1998-10-20 2001-11-20 Mitsubishi Denki Kabushiki Kaisha Fluid dielectric constant sensing device and method employing the same
US6723048B2 (en) * 1999-12-28 2004-04-20 Pindi Products, Inc. Method and apparatus for non-invasive analysis of blood glucose
US20020155615A1 (en) * 2001-02-05 2002-10-24 Novikov Igor A. Method of determining concentration of glucose in blood
US20040147819A1 (en) * 2001-03-06 2004-07-29 Andreas Caduff Impedance spectroscopy based systems and methods
US20040104736A1 (en) * 2001-03-13 2004-06-03 Emanuel Cohen Apparatus and method for analysing fluids
US20040133353A1 (en) * 2001-04-12 2004-07-08 Geutebrueck Ernst Method and device for detecting functional and metabolic data of a living organism
US20050113662A1 (en) * 2001-04-27 2005-05-26 Nasr-Eddine Djennati Emanuel Cohen Magnetic sensor and method for analysing a fluid
US20040240512A1 (en) * 2001-06-21 2004-12-02 Benny Pesach Permittivity based temperature measurement and related methods
US20050101842A1 (en) * 2002-09-20 2005-05-12 Nihon Seimitsu Sokki Co., Ltd. Electronic device for health index measurement and control method of the same
US6954662B2 (en) * 2003-08-19 2005-10-11 A.D. Integrity Applications, Ltd. Method of monitoring glucose level

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160007891A1 (en) * 2004-02-05 2016-01-14 Dermal Devices Inc. Method and Apparatus for Measuring Glucose in Body Fluids Using Sub-Dermal Body Tissue Impedance Measurements
US9833178B2 (en) * 2004-02-05 2017-12-05 D.T.R. Dermal Therapy Research Inc. Method and apparatus for measuring glucose in body fluids using sub-dermal body tissue impedance measurements
WO2012011066A1 (en) * 2010-07-21 2012-01-26 Kyma Medical Technologies Ltd. Implantable dielectrometer
US9788752B2 (en) 2010-07-21 2017-10-17 Zoll Medical Israel Ltd. Implantable dielectrometer
WO2015175654A1 (en) * 2014-05-13 2015-11-19 Auburn University Capacitive fringing field sensors and electrical conductivity sensors integrated into printed circuit boards
DE102014014071A1 (en) * 2014-09-29 2016-03-31 Trw Automotive Gmbh Vehicle operating element as well as methods for the noninvasive measurement of biomolecules

Also Published As

Publication number Publication date Type
US7315767B2 (en) 2008-01-01 grant
US20040147819A1 (en) 2004-07-29 application

Similar Documents

Publication Publication Date Title
Clark et al. Bioelectrodes for tissue metabolism
Haemmerich et al. In vivo electrical conductivity of hepatic tumours
US6872298B2 (en) Determination of sample volume adequacy in biosensor devices
US6595919B2 (en) Device for signal processing for measurement of physiological analytes
US6272364B1 (en) Method and device for predicting physiological values
Winquist et al. Monitoring of freshness of milk by an electronic tongue on the basis of voltammetry
Matzeu et al. Advances in wearable chemical sensor design for monitoring biological fluids
US6587715B2 (en) Assessment of organs for transplant, xenotransplant, and predicting time of death
US6391643B1 (en) Kit and method for quality control testing of an iontophoretic sampling system
US20040108226A1 (en) Continuous glucose quantification device and method
US6816742B2 (en) Biosensor and methods of use thereof
US20100025238A1 (en) Analyte sensor apparatuses having improved electrode configurations and methods for making and using them
US7866026B1 (en) Method for making calibration-adjusted sensors
US6180416B1 (en) Method and device for predicting physiological values
Rigaud et al. In vitro tissue characterization and modelling using electrical impedance measurements in the 100 Hz-10 MHz frequency range
Ong et al. Monitoring of bacteria growth using a wireless, remote query resonant-circuit sensor: application to environmental sensing
So et al. Recent advances in noninvasive glucose monitoring
US20100030045A1 (en) Analyte sensor apparatuses comprising multiple implantable sensor elements and methods for making and using them
US20080269581A1 (en) Method and apparatus for measuring blood volume
US20130316442A1 (en) Monitoring system for cell culture
Netz et al. Contactless impedance measurement by magnetic induction-a possible method for investigation of brain impedance
US6653091B1 (en) Method and device for predicting physiological values
US20060293576A1 (en) Protrudent analyte sensor
Grimnes et al. Sources of error in tetrapolar impedance measurements on biomaterials and other ionic conductors
US20060178573A1 (en) System and method for piercing dermal tissue

Legal Events

Date Code Title Description
AS Assignment

Owner name: PENDRAGON MEDICAL LTD., SWITZERLAND

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:CADUFF, ANDREAS;HIRT, ETIENNE;SCHREPFER, THOMAS W.;REEL/FRAME:015186/0866;SIGNING DATES FROM 20040224 TO 20040308

Owner name: PENDRAGON MEDICAL LTD., SWITZERLAND

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:CADUFF, ANDREAS;HIRT, ETIENNE;SCHREPFER, THOMAS W.;SIGNING DATES FROM 20040224 TO 20040308;REEL/FRAME:015186/0866

AS Assignment

Owner name: SOLIANIS HOLDING AG, SWITZERLAND

Free format text: LETTER FROM OFFICE OF BANKRUPTCY OF OERLIKON-ZURICH INDICATING THE RESULTS OF AN AUCTION;ASSIGNOR:PENDRAGON MEDICAL, LTD.;REEL/FRAME:018151/0920

Effective date: 20050411

Owner name: SOLIANIS HOLDING AG,SWITZERLAND

Free format text: LETTER FROM OFFICE OF BANKRUPTCY OF OERLIKON-ZURICH INDICATING THE RESULTS OF AN AUCTION;ASSIGNOR:PENDRAGON MEDICAL, LTD.;REEL/FRAME:018151/0920

Effective date: 20050411

AS Assignment

Owner name: SOLIANIS HOLDING AG, SWITZERLAND

Free format text: NOTICE OF ASSIGNEE ADDRESS CHANGE;ASSIGNOR:SOLIANIS HOLDING AG;REEL/FRAME:020317/0577

Effective date: 20080104

REMI Maintenance fee reminder mailed
LAPS Lapse for failure to pay maintenance fees
FP Expired due to failure to pay maintenance fee

Effective date: 20120101